Research ExplorerPublicationsReduced CD151 expression is related to advanced tumour stage...

Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer

Standard

Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer. / Minner, Sarah Jane Pauline; De Silva, Colin; Rink, Michael; Dahlem, Roland; Chun, Felix; Fisch, Margit; Höppner, Wolfgang; Wagner, Walter; Bokemeyer, Carsten; Terracciano, Luigi; Simon, Ronald; Sauter, Guido; Wilczak, Waldemar.

In: PATHOLOGY, Vol. 44, No. 5, 5, 08.2012, p. 448-452.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Minner, SJP, De Silva, C, Rink, M, Dahlem, R, Chun, F, Fisch, M, Höppner, W, Wagner, W, Bokemeyer, C, Terracciano, L, Simon, R, Sauter, G & Wilczak, W 2012, 'Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer', PATHOLOGY, vol. 44, no. 5, 5, pp. 448-452. https://doi.org/10.1097/PAT.0b013e32835576ee

APA

Minner, S. J. P., De Silva, C., Rink, M., Dahlem, R., Chun, F., Fisch, M., Höppner, W., Wagner, W., Bokemeyer, C., Terracciano, L., Simon, R., Sauter, G., & Wilczak, W. (2012). Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer. PATHOLOGY, 44(5), 448-452. [5]. https://doi.org/10.1097/PAT.0b013e32835576ee

Vancouver

Minner SJP, De Silva C, Rink M, Dahlem R, Chun F, Fisch M et al. Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer. PATHOLOGY. 2012 Aug;44(5):448-452. 5. https://doi.org/10.1097/PAT.0b013e32835576ee

Bibtex

@article{10a3a72790244c8fabf8a795e2676b36,
title = "Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer",
abstract = "CD151 belongs to the group of tetraspanins and is aberrantly expressed in different tumours and differential expression has been associated with prognosis. The aim of this study was to clarify the relationship of CD151 expression with tumour phenotype and clinical outcome in bladder cancer.",
keywords = "Biomarkers, Tumor, Carcinoma, Transitional Cell, Cell Adhesion, Disease Progression, Humans, Immunohistochemistry, Prognosis, Recurrence, Survival Rate, Tetraspanin 24, Tissue Array Analysis, Urinary Bladder, Urinary Bladder Neoplasms, Urothelium, Journal Article",
author = "Minner, {Sarah Jane Pauline} and {De Silva}, Colin and Michael Rink and Roland Dahlem and Felix Chun and Margit Fisch and Wolfgang H{\"o}ppner and Walter Wagner and Carsten Bokemeyer and Luigi Terracciano and Ronald Simon and Guido Sauter and Waldemar Wilczak",
year = "2012",
month = aug,
doi = "10.1097/PAT.0b013e32835576ee",
language = "English",
volume = "44",
pages = "448--452",
journal = "PATHOLOGY",
issn = "0031-3025",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer

AU - Minner, Sarah Jane Pauline

AU - De Silva, Colin

AU - Rink, Michael

AU - Dahlem, Roland

AU - Chun, Felix

AU - Fisch, Margit

AU - Höppner, Wolfgang

AU - Wagner, Walter

AU - Bokemeyer, Carsten

AU - Terracciano, Luigi

AU - Simon, Ronald

AU - Sauter, Guido

AU - Wilczak, Waldemar

PY - 2012/8

Y1 - 2012/8

N2 - CD151 belongs to the group of tetraspanins and is aberrantly expressed in different tumours and differential expression has been associated with prognosis. The aim of this study was to clarify the relationship of CD151 expression with tumour phenotype and clinical outcome in bladder cancer.

AB - CD151 belongs to the group of tetraspanins and is aberrantly expressed in different tumours and differential expression has been associated with prognosis. The aim of this study was to clarify the relationship of CD151 expression with tumour phenotype and clinical outcome in bladder cancer.

KW - Biomarkers, Tumor

KW - Carcinoma, Transitional Cell

KW - Cell Adhesion

KW - Disease Progression

KW - Humans

KW - Immunohistochemistry

KW - Prognosis

KW - Recurrence

KW - Survival Rate

KW - Tetraspanin 24

KW - Tissue Array Analysis

KW - Urinary Bladder

KW - Urinary Bladder Neoplasms

KW - Urothelium

KW - Journal Article

U2 - 10.1097/PAT.0b013e32835576ee

DO - 10.1097/PAT.0b013e32835576ee

M3 - SCORING: Journal article

C2 - 22772340

VL - 44

SP - 448

EP - 452

JO - PATHOLOGY

JF - PATHOLOGY

SN - 0031-3025

IS - 5

M1 - 5

ER -